Related references
Note: Only part of the references are listed.Long-term outcomes after reduced-intensity conditioning allogeneic stem cell transplantation for low-grade lymphoma:: a survey by the French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC)
Stephane Vigouroux et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2007)
Heterogeneous CD52 expression among hematologic neoplasms: Implications for the use of alemtuzumab (CAMPATH-1H)
Scott J. Rodig et al.
CLINICAL CANCER RESEARCH (2006)
A risk score for mortality after allogeneic hematopoietic cell transplantation
T Parimon et al.
ANNALS OF INTERNAL MEDICINE (2006)
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
ML Sorror et al.
BLOOD (2005)
High-dose therapy followed by autologous purged stem-cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by GOELAMS
E Deconinck et al.
BLOOD (2005)
Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies
D Valcárcel et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2005)
BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients
RD Faulkner et al.
BLOOD (2004)
Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma
E Morris et al.
BLOOD (2004)
Myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission prolongs progression-free survival in follicular lymphoma: results of a prospective, randomized trial of the German Low-Grade Lymphoma Study Group
G Lenz et al.
BLOOD (2004)
Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma
K van Besien et al.
BLOOD (2003)
Secondary myelodysplastic syndrome and acute myelogenous leukemia are significant complications following autologous stem cell transplantation for lymphoma
R Howe et al.
BONE MARROW TRANSPLANTATION (2003)
Reduced-intensity rituximab-BEAM-CAMPATH allogeneic haematopoietic stem cell transplantation for follicular lymphoma is feasible and induces durable molecular remissions
AYL Ho et al.
BONE MARROW TRANSPLANTATION (2003)
High-dose, therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin's lymphoma: Results from the randomized European CUP trial
HC Schouten et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Graft-versus-lymphoma effect of donor lymphocyte infusion in indolent lymphomas relapsed after allogeneic stem cell transplantation
CMPW Mandigers et al.
BONE MARROW TRANSPLANTATION (2003)
Respiratory virus infections in transplant recipients after reduced-intensity conditioning with Campath-1H: high incidence but low mortality
S Chakrabarti et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Nonmyeloablative transplantation with or without alemtuzumab:: comparison between 2 prospective studies in patients with lymphoproliferative disorders
JA Pérez-Simón et al.
BLOOD (2002)
Role of nonmyeloablative allogeneic stem-cell transplantation after failure of autologous transplantation in patients with lymphoproliferative malignancies
K Branson et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery
S Chakrabarti et al.
BLOOD (2002)
High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution
S Chakrabarti et al.
BLOOD (2002)
Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality
IF Khouri et al.
BLOOD (2001)
Allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning:: results of a prospective multicentre study
R Martino et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH conditioning: an effective regimen with low procedure-related toxicity
GM Cull et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
Share Paper
